重症肌无力对胸腺瘤患者预后的影响  

The influence of myasthenia gravis on the prognosis of thymoma patients

作　　者：庞烈文[1] 汪昉睿[1] 方文涛[2] 

机构地区：[1]复旦大学华山医院胸外科,上海200040 [2]上海交通大学附属胸科医院胸外科,200030

出　　处：《中华胸心血管外科杂志》2017年第3期133-134,共2页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：重症肌无力（MG）对胸腺瘤的预后影响在既往回顾性研究文献中结果不一,可分类为有利、不利、无关三种影响方式.最近中国胸腺疾病协作组（ChART）的关于重症肌无力对胸腺瘤患者预后影响的文章报道不同的临床分期下,合并MG对预后的影响是不同的.综合文献结果,MG对胸腺瘤患者预后的影响是复杂的,包括严重的MG相关并发症带来的直接不利影响,以及其病理分型和临床分期特点的间接有利影响.MG治疗的不断进展可减少其直接影响,改善胸腺瘤的预后.Objective The influence of myasthenia gravias（MG） upon the long term survival of thoma patients varied in the retrospective studies as reported,including the positive,negative impact and irrelevant influence.The recent study from the Chinese Alliance for Research on Thynic Diseses（ChART） indicated that in different stages of thymoma,MG influenced the prognosis in different ways.It＆#39;s the author＆#39;s conclusion that the complicated influences of MG on the prognosis of thymoma include a direct one which is negative resulting from MG related complications and an indirect positive one due to its beneficial pathologic and staging patterns.Inprovement of the prognosis for patients with thymoma complicating MG will be expected with advancement in MG therapeutics.

关 键 词：重症肌无力 胸腺瘤 预后 

分 类 号：R746.1[医药卫生—神经病学与精神病学]